These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25145542)

  • 21. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
    Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
    Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.
    Mille B; Watton J; Barrowcliffe TW; Mani JC; Lane DA
    J Biol Chem; 1994 Nov; 269(47):29435-43. PubMed ID: 7961924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1H NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments.
    Horne A; Gettins P
    Biochemistry; 1992 Mar; 31(8):2286-94. PubMed ID: 1311598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue.
    Torri G; Casu B; Gatti G; Petitou M; Choay J; Jacquinet JC; Sinaÿ P
    Biochem Biophys Res Commun; 1985 Apr; 128(1):134-40. PubMed ID: 3985961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformation of the pentasaccharide corresponding to the binding site of heparin for antithrombin III.
    Ragazzi M; Ferro DR; Perly B; Sinaÿ P; Petitou M; Choay J
    Carbohydr Res; 1990 Jan; 195(2):169-85. PubMed ID: 2331700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introducing a C-interglycosidic bond in a biologically active pentasaccharide hardly affects its biological properties.
    Petitou M; Hérault JP; Lormeau JC; Helmboldt A; Mallet JM; Sinaÿ P; Herbert JM
    Bioorg Med Chem; 1998 Sep; 6(9):1509-16. PubMed ID: 9801822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the induced fit mechanism in antithrombin-heparin interaction using molecular dynamics simulations.
    Verli H; Guimarães JA
    J Mol Graph Model; 2005 Dec; 24(3):203-12. PubMed ID: 16146701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide.
    Quinsey NS; Whisstock JC; Le Bonniec B; Louvain V; Bottomley SP; Pike RN
    J Biol Chem; 2002 May; 277(18):15971-8. PubMed ID: 11854268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
    Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
    Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue.
    Guerrini M; Guglieri S; Casu B; Torri G; Mourier P; Boudier C; Viskov C
    J Biol Chem; 2008 Sep; 283(39):26662-75. PubMed ID: 18640975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled.
    Parafioriti M; Elli S; Muñoz-García JC; Ramírez-Cárdenas J; Yates EA; Angulo J; Guerrini M
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin.
    Lane DA; Flynn AM; Pejler G; Lindahl U; Choay J; Preissner K
    J Biol Chem; 1987 Dec; 262(34):16343-8. PubMed ID: 2445746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
    Shriver Z; Raman R; Venkataraman G; Drummond K; Turnbull J; Toida T; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10359-64. PubMed ID: 10984531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
    Desai UR; Petitou M; Björk I; Olson ST
    J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
    Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
    J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.
    Nieto L; Canales Á; Giménez-Gallego G; Nieto PM; Jiménez-Barbero J
    Chemistry; 2011 Sep; 17(40):11204-9. PubMed ID: 21922554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics in aqueous solutions of the pentasaccharide corresponding to the binding site of heparin for antithrombin III studied by NMR relaxation measurements.
    Hricovíni M; Torri G
    Carbohydr Res; 1995 Mar; 268(2):159-75. PubMed ID: 7736468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of heparin. Enzymatic sulfation of pentasaccharides.
    Kusche M; Oscarsson LG; Reynertson R; Rodén L; Lindahl U
    J Biol Chem; 1991 Apr; 266(12):7400-9. PubMed ID: 1902219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.